These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30715781)

  • 1. Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: A case series.
    Davis AB; Schnabel LV; Gilger BC
    Vet Ophthalmol; 2019 Sep; 22(5):674-682. PubMed ID: 30715781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing advanced therapeutics through the study of naturally occurring immune-mediated ocular disease in domestic animals.
    Gilger BC
    Am J Vet Res; 2022 Oct; 83(11):. PubMed ID: 36201404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of corneal autoantibodies in horses with immune mediated keratitis (IMMK).
    Braus BK; Miller I; Kummer S; Kleinwort KJH; Hirmer S; Hauck SM; McMullen RJ; Kerschbaumer M; Deeg CA
    Vet Immunol Immunopathol; 2017 May; 187():48-54. PubMed ID: 28494929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subconjunctival autologous muscle-derived mesenchymal stem cell therapy: A novel, minimally invasive approach for treating equine immune-mediated keratitis.
    Narinx F; Sauvage A; Ceusters J; Grulke S; Serteyn D; Monclin S
    Vet Ophthalmol; 2023 Dec; ():. PubMed ID: 38071501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser scanning in vivo confocal microscopic characterization of equine immune-mediated keratitis.
    Ledbetter EC; Irby NL
    Vet Ophthalmol; 2020 Jan; 23(1):4-15. PubMed ID: 31050168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro.
    Sherman AB; Gilger BC; Berglund AK; Schnabel LV
    Stem Cell Res Ther; 2017 May; 8(1):120. PubMed ID: 28545510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and immunopathologic characterization of superficial stromal immune-mediated keratitis in horses.
    Pate DO; Clode AB; Olivry T; Cullen JM; Salmon JH; Gilger BC
    Am J Vet Res; 2012 Jul; 73(7):1067-73. PubMed ID: 22738059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?
    De Schauwer C; Van de Walle GR; Van Soom A; Meyer E
    Vet Q; 2013 Dec; 33(4):234-41. PubMed ID: 23697553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated keratitis in horses: 19 cases (1998-2004).
    Gilger BC; Michau TM; Salmon JH
    Vet Ophthalmol; 2005; 8(4):233-9. PubMed ID: 16008702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected malignant transformation of B lymphocytes in the equine cornea from immune-mediated keratitis.
    Vallone LV; Neaderland MH; Ledbetter EC; Dubielzig RR
    Vet Ophthalmol; 2016 Mar; 19(2):172-9. PubMed ID: 25919039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
    Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
    Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HORSE SPECIES SYMPOSIUM: Use of mesenchymal stem cells in fracture repair in horses.
    Govoni KE
    J Anim Sci; 2015 Mar; 93(3):871-8. PubMed ID: 26020865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.
    Gilger BC; Stoppini R; Wilkie DA; Clode AB; Pinto NH; Hempstead J; Gerding J; Salmon JH
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():23-30. PubMed ID: 23910236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
    Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.
    Caniglia CJ; Schramme MC; Smith RK
    Equine Vet J; 2012 Sep; 44(5):587-93. PubMed ID: 22150794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
    Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
    Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
    Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
    Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.